Not Signed In - Pixantrone Produces High Rate (77 Percent) Of Complete Tumor Disappearance In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma
Thu, 18 May 2006 06:00 AM EST
... Preliminary results of a phase I/II study of pixantrone combined with fludarabine, dexamethasone, and rituximab for treatment of patients with relapsed indolent non-Hodgkin's lymphoma (NHL) will be presented today at the Rodman & Renshaw 3rd Annual Global Healthcare Conference in Monte Carlo, Monaco. [click link for full article] ...
Related Topics
- Hodgkin's Lymphoma
- Non-Hodgkin's Lymphoma
- Lymphoma
- Brain Tumor
- Benign Tumors
- Benign Tumor
- Adult Non-Hodgkin's Lymphoma
- Non-Hodgkin's Lymphoma, Adult
- Non-Hodgkin's Lymphoma During Pregnancy
- Childhood Hodgkin's Lymphoma
- Pregnancy and Hodgkin's Lymphoma
- Pregnancy and Non-Hodgkin's Lymphoma
- Non-Hodgkin's Lymphoma, Childhood
- Lymphoma, Non-Hodgkin's During Pregnancy
- Hodgkin's Lymphoma During Pregnancy
- Lymphoma, Hodgkin's, Adult
- Lymphoma, Non-Hodgkin's, Adult
- Lymphoma, Hodgkin's During Pregnancy
- Hodgkin's Lymphoma, Childhood
- Lymphoma, Non-Hodgkin's, Childhood
email this page
print this page
bookmark this page
feedback on this page
